Smith & Nephew 

GBX1,167
415
-GBX1.5-0.13% 今天

统计数据

当日最高
1,167
当日最低
1,163
52周最高
-
52周最低
-
成交量
11,945.53
平均成交量
-
市值
10.19B
市盈率
43.28
股息收益率
2.53%
股息
29.57

即将到来

股息

2.53%股息收益率
10年增长
4.64%
5年增长
1%
3年增长
2.97%
1年增长
-2.18%

收益

1Aug已确认
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
0
16.07
32.13
48.2
预期每股收益
0.3928
实际每股收益
0.376

人们还关注

此列表基于关注SN.LSE的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。
Stryker
SYK
市值128.76B
斯特赖克公司是一家直接竞争对手,提供类似的骨科和医疗设备范围。
Medtronic
MDT
市值108.51B
Medtronic plc专注于医疗技术、服务和解决方案,包括外科设备,与史密夫和内修(Smith & Nephew)在部分重叠领域竞争。
Zimmer Biomet
ZBH
市值22.53B
Zimmer Biomet Holdings, Inc. 在骨骼肌肉健康产品制造领域与史密夫和内修的产品线直接重叠。
Johnson & Johnson
JNJ
市值383.69B
强生公司通过其子公司德普合成公司在医疗器械领域开展业务,后者在整形外科领域与史密夫和内修公司展开竞争,这是一个关键领域。
Boston Scientific
BSX
市值115.23B
波士顿科学公司在医疗器械市场上与史密斯和内修竞争,特别是在先进外科和伤口护理产品领域。
Intuitive Surgical
ISRG
市值170.21B
Intuitive Surgical, Inc.提供机器人辅助手术系统,与史密夫和内修的先进手术技术竞争。
Abbott Laboratories
ABT
市值193.13B
Abbott Laboratories在各种医疗领域竞争,包括与Smith & Nephew的投资组合重叠的医疗设备。
Baxter International
BAX
市值18.43B
百特国际公司提供广泛的医院和外科产品,在医疗用品和设备领域竞争。
Globus Medical
GMED
市值9.91B
Globus Medical, Inc. 是一家专注于脊椎和骨科手术的公司,直接与史密斯和内修在骨科手术市场竞争。
Edwards Lifesciences
EW
市值41.52B
爱德华生命科学公司专门从事心脏和重症护理产品,在医疗器械市场间接竞争。

关于

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Show more...
首席执行官
Dr. Deepak S. Nath Ph.D.
员工
18000
国家
GB
ISIN
GB0009223206
WKN
000502816

上市公司